FCPA and Anti-Corruption. Except for those matters which, individually or in the aggregate, would not reasonably be expected to have a Company Material Adverse Effect:
Appears in 8 contracts
Samples: Agreement and Plan of Merger (Towers Watson & Co.), Agreement and Plan of Merger (Willis Group Holdings PLC), Agreement and Plan of Merger (Allergan Inc)
FCPA and Anti-Corruption. (a) Except for those matters which, individually or in the aggregate, would not reasonably be expected to have a Company an Aon Material Adverse Effect:
Appears in 6 contracts
Samples: Business Combination Agreement, Business Combination Agreement (Aon PLC), Business Combination Agreement (Willis Towers Watson PLC)
FCPA and Anti-Corruption. Except for those matters whichas would not reasonably be expected to have, individually or in the aggregate, would not reasonably be expected to have a Company Material Adverse Effect, since January 1, 2014:
Appears in 1 contract
Samples: Agreement and Plan of Merger (Anacor Pharmaceuticals, Inc.)
